About UsInvestors
Video
Learn more about DermTech’s EGIR® Technology »
Melanoma Facts
- By 2010, current estimates indicate 1:50 people will be diagnosed with melanoma during their lifetime.
- Melanoma is the most common cancer in women aged 25-29.
- If melanoma is treated before it spreads it is 95-99% curable
Headquartered in La Jolla, California, DermTech International develops molecular biology assays to identify, diagnose and/or analyze any number of disease states or conditions, the genetic footprints of which can be found on the stratum corneum by using DermTech's proprietary EGIR® technology. If you wish to learn more, please contact us:
Gary Jacobs, Chairman and Acting CEO
Ph: (858) 450-4222
gjacobs@jacobsllc.com
gjacobs@dermtech.com